Imatinib Terminated Phase 1 Trials for Chronic Myeloid Leukemia (CML) / Other Glivec/Gleevec Indicated Hematological Disorders (HES, CEL, MDS/ MPN) / Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (Ph+ ALL)

IndicationsStatusPurposePhase
TerminatedNot Available1
clinicaltrials.gov IdentifierTitleDrugs
NCT01066468Glivec/Gleevec Pediatric (Age 1 to Less Than 4) PK Study in CML, Ph+ ALL Patients and Other Glivec/GleevecĀ® Indicated Hematological Disorders.